Jaguar Health, Inc

(NASDAQ:JAGX)

Latest On Jaguar Health, Inc (JAGX):

Date/Time Type Description Signal Details
2023-05-16 01:05 ESTNewsJaguar Health, Inc. (JAGX) Q1 2023 Earnings Call TranscriptN/A
2023-05-15 11:24 ESTNewsJaguar Health GAAP EPS of -$2.39, revenue of $1.97MN/A
2023-04-11 15:09 ESTNewsJaguar Health completes 90% enrollment for diarrhea in adult cancer patients treatment trialN/A
2023-04-06 15:12 ESTNewsJaguar plans further scrutiny to detect potential illegal short sellingN/A
2023-03-27 16:39 ESTNewsJaguar Health GAAP EPS of -$36.18, revenue of $11.96MN/A
2023-03-27 16:38 ESTNewsJaguar Health in red after ramp-up in 2022 Mytesi revenue misses estimatesN/A
2023-03-27 16:38 ESTNewsJaguar Health, Inc. (JAGX) Q4 2022 Earnings Call TranscriptN/A
2023-02-23 16:04 ESTNewsJaguar Health spikes on patent win for antidiarrheal therapyN/A
2023-02-13 21:27 ESTNewsJaguar Health announces private placement for Italian unitN/A
2023-01-26 21:46 ESTNewsJaguar Health to submit application to begin trial for ultra-rare congenital diarrheal disorder in H1N/A
2023-01-10 23:39 ESTNewsJaguar, Filament, One Small Planet form JV to develop plant-based drugs for mental disordersN/A
2022-11-15 03:44 ESTNewsJaguar Health (JAGX) Q3 2022 Earnings Call TranscriptN/A
2022-11-15 03:44 ESTNewsJaguar trades lower despite Q3 revenue soaring 400%N/A
2022-11-14 10:27 ESTNewsJaguar Health GAAP EPS of -$0.12 misses by $0.05, revenue of $3.15M misses by $0.38MN/A
2022-11-11 11:54 ESTNewsJaguar Health Q3 2022 Earnings PreviewN/A
2022-10-17 16:22 ESTNewsJaguar Health rises 19% on orphan drug tag for congenital diarrheal disorder treatmentN/A
2022-08-30 22:31 ESTNewsJaguar seeks FDA nod to start trial of NP-300 for diarrhea relief in choleraN/A
2022-08-25 14:08 ESTNewsJaguar Health sells crofelemer and lechlemer royalty rights for $4M upfrontN/A
2022-08-24 05:40 ESTNewsJaguar's diarrhea disorder therapy gets FDA review for orphan drug statusN/A
2022-08-23 04:46 ESTNewsJaguar Health GAAP EPS of -$0.12, revenue of $2.92MN/A
2022-08-23 04:45 ESTNewsJaguar Health falls 11% as Mytesi gross product revenue declinesN/A
2022-08-23 04:45 ESTNewsJaguar Health, Inc.'s (JAGX) CEO Lisa Conte on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-20 03:17 ESTNewsJaguar Health gets 180-day grace period to regain compliance with Nasdaq's listing ruleN/A
2022-08-20 03:17 ESTNewsJaguar Health Q2 2022 Earnings PreviewN/A
2022-08-10 01:47 ESTNewsJaguar Health rises on U.S. patent for treating chemotherapy-induced diarrheaN/A
2022-06-29 18:35 ESTNewsJaguar stock rises on license deal with SynWorld for Canalevia in ChinaN/A
2022-06-14 01:54 ESTNewsJaguar Health highlights importance of controlling diarrhea in cancer patientsN/A
2022-06-09 16:24 ESTNewsJaguar, Filament team up to develop botanical drugs for mental health disordersN/A
2022-05-25 18:53 ESTNewsJaguar Health's Italian firm applies for orphan drug designation for crofelemer to EMAN/A
2022-05-11 05:04 ESTNewsJaguar Health GAAP EPS of -$0.40 misses by $0.23, revenue of $2.62M beats by $1MN/A
2022-05-11 05:04 ESTNewsJaguar Health, Inc. (JAGX) CEO Lisa Conte on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 07:30 ESTNewsJaguar Health Q1 2022 Earnings PreviewN/A
2022-04-02 00:24 ESTNewsJaguar Health pares off gains in early trading after March 31 rally on back of license dealN/A
2022-03-31 12:13 ESTNewsJaguar Health stock rises 11% on license deal for crofelemer in Middle East marketsN/A
2022-03-16 03:16 ESTNewsJaguar Health defended at Cantor; says Crofelemer potential “underappreciated”N/A
2022-03-15 05:02 ESTNewsJaguar Health, Inc. (JAGX) CEO Lisa Conte on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-12 07:31 ESTNewsJaguar Health GAAP EPS of -$1.18 misses by $0.46, revenue of $4.34M misses by $6.32MN/A
2022-03-07 21:32 ESTNewsJaguar Health CEO Lisa Conte - From Rainforest To LaboratoryN/A
2022-02-16 22:26 ESTNewsJaguar Health seeks 'orphan drug' status for diarrhea med for dogsN/A
2022-02-11 04:47 ESTNewsJaguar Health files for conditional FDA approval of canine therapy CanaleviaN/A
2022-01-13 16:41 ESTNewsJaguar Health plans awareness activities for launch of chemo-related dog drug CanaleviaN/A
2021-12-21 23:04 ESTNewsJaguar Health wins FDA OK for canine therapyN/A
2021-12-09 22:01 ESTNewsJaguar Health (JAGX) Investor Presentation - SlideshowN/A
2021-11-17 19:44 ESTNewsJaguar Health, Inc. (JAGX) CEO Lisa Conte on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-27 20:20 ESTNewsJaguar Health pares gains from Italian regulatory approval of merger; shares down 15%N/A
2021-10-14 19:58 ESTNewsWarning: JAGX is at high risk of performing badlyN/A
2021-09-07 15:20 ESTNewsJaguar Health slide continues following reverse stock split; shares down 21%N/A
2021-09-03 17:29 ESTNewsJaguar Health slumps 10% on 1-for-3 reverse stock split announcementN/A
2021-08-20 05:10 ESTNewsNapo Pharmaceuticals inks licensing agreement to develop crofelemer and lechlemer in EuropeN/A
2021-08-17 15:28 ESTNewsNapo Pharmaceuticals completes additional preclinical toxicology study for NP-300N/A

About Jaguar Health, Inc (JAGX):

Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. It operates through two reportable segments, Human Health and Animal Health. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its human health product pipelines include crofelemer, which is in Phase III clinical trial for the treatment of cancer therapy-related diarrhea, as well as for the supportive care for inflammatory bowel disease; formulation of crofelemer that is Phase II clinical trial for the treatment of short bowel syndrome, congenital diarrheal disorders, idiopathic/functional diarrhea, and irritable bowel; and SB-300, a second-generation anti-secretory agent for various indications, including cholera. The company's animal health product candidates comprise Canalevia, an animal prescription drug product candidate intended for treatment of chemotherapy-induced diarrhea in dogs; and Equilevia, a non-prescription product for total gut health in equine athletes. In addition, its products include Neonorm Calf and Neonorm Foal. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.

JAGX Quotes by TradingView

See Advanced Chart

General

  • Name Jaguar Health, Inc
  • Symbol JAGX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 29
  • Last Split Factor1:70
  • Last Split Date2019-06-07
  • Fiscal Year EndDecember
  • IPO Date2015-05-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.jaguar.health
View More

Valuation

  • Trailing PE 0.06
  • Price/Sales (Trailing 12 Mt.) 5.94
  • Price/Book (Most Recent Quarter) 120.77
  • Enterprise Value Revenue 32.4
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.09
  • Operating Margin -266%
  • Return on Assets -39%
  • Return on Equity -220%
  • Revenue 8.32 million
  • Earnings Per Share -$79.45
  • Revenue Per Share $0.37
  • Gross Profit -3782372
  • Quarterly Earnings Growth 185%
View More

Highlights

  • Market Capitalization 251.54 million
  • EBITDA -24270258
  • PE Ratio -1.1
  • PEG Ratio -0.02
  • Analyst Target Price $3.75
  • Book Value Per Share $0.04
View More

Share Statistics

  • Shares Outstanding 117.82 million
  • Shares Float 65.17 million
  • % Held by Insiders 801%
  • % Held by Institutions 6.7%
  • Shares Short 3.39 million
  • Shares Short Prior Month 3.49 million
  • Short Ratio 0.17
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.49
  • 52 Week High $4.47
  • 52 Week Low $0.19
  • 50 Day Moving Average 2.48
  • 200 Day Moving Average 1.2
View More

Dividends

  • Dividend Date 2019-06-07
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Jaguar Health, Inc (JAGX) Dividend Calendar:

JAGX's last dividend payment was made to shareholders on June 7, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Jaguar Health, Inc (JAGX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A-$0.21-$0.11-90.91%
2020-06-302020-08-13$N/A-$0.44-$0.15-193.33%
2020-03-312020-04-03$869000-$0.68-$0.67-1.49%
2019-09-302019-11-14$972779-$2.00-$0.77-159.74%
2019-06-302019-08-14$1.71 million-$15.11-$5.29-185.63%
2019-03-312019-05-21$1.59 million-$16.80-$13.30-26.32%
2018-12-312019-03-13$1.6 million-$13.65
2018-09-302018-11-19$1.13 million-$35.62-$136.5073.9%
2018-06-302018-08-13$883846-$53.24
2018-03-312018-04-09$804356-$54.27-$136.5060.24%
2017-12-312018-03-14$1.54 million-$201.45
2017-09-302017-11-20$1.1 million$73.50-$136.50153.85%
2017-06-302017-08-09$895000-$126.00-$231.0045.45%
2017-03-312017-05-15$823000-$349.72
2016-12-312017-02-15$28877-$4.20-$0.24-1650%
2016-09-302016-11-14$50357-$4.50-$0.40-1025%
2016-06-302016-08-15$24143-$0.35-$0.387.89%
2016-03-312016-05-10$38146-$0.43-$0.4912.24%
2015-12-312016-03-29$36554-$0.42-$0.6434.38%
2015-09-302015-11-13$77666-$0.36-$0.4926.53%
2015-06-302015-08-13$78665-$1,052.19

Jaguar Health, Inc (JAGX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Jaguar Health, Inc (JAGX) Chart:

Jaguar Health, Inc (JAGX) News:

Below you will find a list of latest news for Jaguar Health, Inc (JAGX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Jaguar Health, Inc (JAGX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest JAGX Trades:

Date Shares Price
Jun 13, 2022 7:26 PM EST100$0.3
Jun 13, 2022 7:31 PM EST100$0.2955
Jun 13, 2022 7:38 PM EST100$0.2994
Jun 13, 2022 7:38 PM EST100$0.2993
Jun 13, 2022 7:45 PM EST100$0.3

Jaguar Health, Inc (JAGX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920078109/0001104659-20-078109-index.htm
2019-04-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000019007388/0000000000-19-007388-index.htm
2019-04-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000019007797/0000000000-19-007797-index.htm
2019-05-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000019008676/0000000000-19-008676-index.htm
2019-06-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000019010054/0000000000-19-010054-index.htm
2019-06-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000019010055/0000000000-19-010055-index.htm
2019-10-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000019014518/0000000000-19-014518-index.htm
2020-04-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000020003131/0000000000-20-003131-index.htm
2020-06-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000020005419/0000000000-20-005419-index.htm
2020-06-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000020005420/0000000000-20-005420-index.htm
2020-06-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000020005535/0000000000-20-005535-index.htm
2020-09-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1585608/000000000020008823/0000000000-20-008823-index.htm
2020-03-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000090266420001668/0000902664-20-001668-index.htm
2019-08-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000091420819000360/0000914208-19-000360-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000091957420000875/0000919574-20-000875-index.htm
2019-04-23PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1585608/000104746919002502/0001047469-19-002502-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1585608/000104746919002701/0001047469-19-002701-index.htm
2019-05-10S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000104746919003023/0001047469-19-003023-index.htm
2019-06-12S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000104746919003594/0001047469-19-003594-index.htm
2019-06-12S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000104746919003596/0001047469-19-003596-index.htm
2019-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1585608/000104746919003682/0001047469-19-003682-index.htm
2019-06-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000104746919003795/0001047469-19-003795-index.htm
2019-06-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000104746919003796/0001047469-19-003796-index.htm
2019-07-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000104746919004012/0001047469-19-004012-index.htm
2019-07-15S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000104746919004164/0001047469-19-004164-index.htm
2019-07-18S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000104746919004247/0001047469-19-004247-index.htm
2019-07-22424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1585608/000104746919004311/0001047469-19-004311-index.htm
2020-04-03PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1585608/000104746920002022/0001047469-20-002022-index.htm
2020-04-13DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1585608/000104746920002257/0001047469-20-002257-index.htm
2020-06-09PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1585608/000104746920003466/0001047469-20-003466-index.htm
2020-06-18PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1585608/000104746920003702/0001047469-20-003702-index.htm
2020-06-19DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1585608/000104746920003733/0001047469-20-003733-index.htm
2020-06-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1585608/000104746920003844/0001047469-20-003844-index.htm
2019-04-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919020718/0001104659-19-020718-index.htm
2019-04-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919022633/0001104659-19-022633-index.htm
2019-04-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465919023108/0001104659-19-023108-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1585608/000110465919024655/0001104659-19-024655-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919026479/0001104659-19-026479-index.htm
2019-05-15NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1585608/000110465919029717/0001104659-19-029717-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919030315/0001104659-19-030315-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919031656/0001104659-19-031656-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919031832/0001104659-19-031832-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919032207/0001104659-19-032207-index.htm
2019-06-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1585608/000110465919033293/0001104659-19-033293-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919033331/0001104659-19-033331-index.htm
2019-06-04RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919033636/0001104659-19-033636-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919034310/0001104659-19-034310-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919035713/0001104659-19-035713-index.htm
2019-06-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465919036402/0001104659-19-036402-index.htm
2019-06-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465919036404/0001104659-19-036404-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919037294/0001104659-19-037294-index.htm
2019-06-288-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919038108/0001104659-19-038108-index.htm
2019-07-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919039384/0001104659-19-039384-index.htm
2019-07-05FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919039447/0001104659-19-039447-index.htm
2019-07-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919040200/0001104659-19-040200-index.htm
2019-07-15FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919040246/0001104659-19-040246-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919040357/0001104659-19-040357-index.htm
2019-07-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465919040553/0001104659-19-040553-index.htm
2019-07-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465919040556/0001104659-19-040556-index.htm
2019-07-19S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1585608/000110465919041041/0001104659-19-041041-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919041472/0001104659-19-041472-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919041839/0001104659-19-041839-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919041840/0001104659-19-041840-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919041841/0001104659-19-041841-index.htm
2019-07-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919042077/0001104659-19-042077-index.htm
2019-07-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919042082/0001104659-19-042082-index.htm
2019-07-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919042085/0001104659-19-042085-index.htm
2019-07-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919042088/0001104659-19-042088-index.htm
2019-07-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919042089/0001104659-19-042089-index.htm
2019-07-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919042090/0001104659-19-042090-index.htm
2019-07-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919042092/0001104659-19-042092-index.htm
2019-08-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1585608/000110465919044580/0001104659-19-044580-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919045966/0001104659-19-045966-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919046526/0001104659-19-046526-index.htm
2019-08-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919046659/0001104659-19-046659-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919046816/0001104659-19-046816-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919049324/0001104659-19-049324-index.htm
2019-09-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465919050142/0001104659-19-050142-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919050905/0001104659-19-050905-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919051205/0001104659-19-051205-index.htm
2019-09-24424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000110465919051209/0001104659-19-051209-index.htm
2019-09-27S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000110465919051819/0001104659-19-051819-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919052870/0001104659-19-052870-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919053249/0001104659-19-053249-index.htm
2019-10-22S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000110465919055590/0001104659-19-055590-index.htm
2019-10-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465919055604/0001104659-19-055604-index.htm
2019-10-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465919056856/0001104659-19-056856-index.htm
2019-10-30424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000110465919057883/0001104659-19-057883-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919062131/0001104659-19-062131-index.htm
2019-11-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1585608/000110465919063659/0001104659-19-063659-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919063663/0001104659-19-063663-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919064300/0001104659-19-064300-index.htm
2019-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919064728/0001104659-19-064728-index.htm
2019-12-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1585608/000110465919075593/0001104659-19-075593-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919076157/0001104659-19-076157-index.htm
2019-12-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465919077360/0001104659-19-077360-index.htm
2020-01-22S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000110465920005956/0001104659-20-005956-index.htm
2020-01-278-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920006829/0001104659-20-006829-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920026263/0001104659-20-026263-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920026299/0001104659-20-026299-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920026303/0001104659-20-026303-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920027071/0001104659-20-027071-index.htm
2020-02-28424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920027087/0001104659-20-027087-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920030255/0001104659-20-030255-index.htm
2020-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920037082/0001104659-20-037082-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920037925/0001104659-20-037925-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920037929/0001104659-20-037929-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920037930/0001104659-20-037930-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920037933/0001104659-20-037933-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920037934/0001104659-20-037934-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920037936/0001104659-20-037936-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920037937/0001104659-20-037937-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920038337/0001104659-20-038337-index.htm
2020-03-26424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920038760/0001104659-20-038760-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920038877/0001104659-20-038877-index.htm
2020-03-31NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1585608/000110465920041238/0001104659-20-041238-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920042746/0001104659-20-042746-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920043411/0001104659-20-043411-index.htm
2020-04-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465920043800/0001104659-20-043800-index.htm
2020-04-06S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000110465920043807/0001104659-20-043807-index.htm
2020-04-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000110465920043832/0001104659-20-043832-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920045583/0001104659-20-045583-index.htm
2020-04-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000110465920046007/0001104659-20-046007-index.htm
2020-04-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465920046012/0001104659-20-046012-index.htm
2020-04-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465920046823/0001104659-20-046823-index.htm
2020-04-15424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920047006/0001104659-20-047006-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920047211/0001104659-20-047211-index.htm
2020-04-16424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920047700/0001104659-20-047700-index.htm
2020-04-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920050505/0001104659-20-050505-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920058890/0001104659-20-058890-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920060053/0001104659-20-060053-index.htm
2020-05-138-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920060468/0001104659-20-060468-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920063005/0001104659-20-063005-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920064444/0001104659-20-064444-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920065481/0001104659-20-065481-index.htm
2020-05-22424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920065483/0001104659-20-065483-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920067084/0001104659-20-067084-index.htm
2020-06-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000110465920070488/0001104659-20-070488-index.htm
2020-06-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465920074643/0001104659-20-074643-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920075302/0001104659-20-075302-index.htm
2020-06-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465920075920/0001104659-20-075920-index.htm
2020-06-25424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920076925/0001104659-20-076925-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920077500/0001104659-20-077500-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920078109/0001104659-20-078109-index.htm
2020-07-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920083467/0001104659-20-083467-index.htm
2020-07-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920085274/0001104659-20-085274-index.htm
2020-07-23424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920085766/0001104659-20-085766-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920091165/0001104659-20-091165-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920093035/0001104659-20-093035-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920094372/0001104659-20-094372-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920095547/0001104659-20-095547-index.htm
2020-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920097635/0001104659-20-097635-index.htm
2020-09-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920101650/0001104659-20-101650-index.htm
2020-09-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920101652/0001104659-20-101652-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920103492/0001104659-20-103492-index.htm
2020-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920103723/0001104659-20-103723-index.htm
2020-09-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920104413/0001104659-20-104413-index.htm
2020-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920104452/0001104659-20-104452-index.htm
2020-09-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1585608/000110465920104481/0001104659-20-104481-index.htm
2020-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920105609/0001104659-20-105609-index.htm
2020-09-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1585608/000110465920106979/0001104659-20-106979-index.htm
2020-09-23424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920107841/0001104659-20-107841-index.htm
2020-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920109139/0001104659-20-109139-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920110707/0001104659-20-110707-index.htm
2020-10-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920111938/0001104659-20-111938-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920111939/0001104659-20-111939-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920112859/0001104659-20-112859-index.htm
2020-10-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920112876/0001104659-20-112876-index.htm
2020-10-098-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920113918/0001104659-20-113918-index.htm
2020-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920113922/0001104659-20-113922-index.htm
2020-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920113937/0001104659-20-113937-index.htm
2020-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920113939/0001104659-20-113939-index.htm
2020-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1585608/000110465920113953/0001104659-20-113953-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920114232/0001104659-20-114232-index.htm
2020-10-22PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920116851/0001104659-20-116851-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1585608/000110465920119268/0001104659-20-119268-index.htm
2020-11-06DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1585608/000110465920122543/0001104659-20-122543-index.htm
2019-08-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000121390019016590/0001213900-19-016590-index.htm
2019-08-26SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000121390019016685/0001213900-19-016685-index.htm
2019-11-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000121390019023582/0001213900-19-023582-index.htm
2020-07-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000121390020016897/0001213900-20-016897-index.htm
2020-01-21SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000153561020000041/0001535610-20-000041-index.htm
2019-05-2110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1585608/000155837019005241/0001558370-19-005241-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1585608/000155837019008174/0001558370-19-008174-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1585608/000155837019010987/0001558370-19-010987-index.htm
2020-04-0310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1585608/000155837020003581/0001558370-20-003581-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1585608/000155837020006635/0001558370-20-006635-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1585608/000155837020010491/0001558370-20-010491-index.htm
2020-09-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000156761920017098/0001567619-20-017098-index.htm
2020-11-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000156761920018672/0001567619-20-018672-index.htm
2020-01-06DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000158560820000001/0001585608-20-000001-index.htm
2020-04-07DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000158560820000002/0001585608-20-000002-index.htm
2020-04-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000158560820000003/0001585608-20-000003-index.htm
2020-09-17DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000158560820000007/0001585608-20-000007-index.htm
2020-06-05DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1585608/000172853620000005/0001728536-20-000005-index.htm
2019-10-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000175392619000207/0001753926-19-000207-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1585608/000175392620000016/0001753926-20-000016-index.htm
2019-06-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1585608/999999999519001411/9999999995-19-001411-index.htm
2019-06-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1585608/999999999519001412/9999999995-19-001412-index.htm
2019-07-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1585608/999999999519001638/9999999995-19-001638-index.htm
2019-10-30EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1585608/999999999519002427/9999999995-19-002427-index.htm
2020-04-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1585608/999999999520000756/9999999995-20-000756-index.htm
2020-04-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1585608/999999999520000766/9999999995-20-000766-index.htm
2020-04-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1585608/999999999520000776/9999999995-20-000776-index.htm
2020-06-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1585608/999999999520001546/9999999995-20-001546-index.htm
2020-09-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1585608/999999999520002548/9999999995-20-002548-index.htm

Jaguar Health, Inc (JAGX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jaguar Health, Inc (JAGX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 801%
Institutional Ownership: 670%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-07-23Jonathan B. SiegelDirectorBuy12,705.002.0025,410.0013,276.00https://www.sec.gov/Archives/edgar/data/1585608/000110465919041841/0001104659-19-041841-index.htm
2019-07-23JAMES J BOCHNOWSKIDirectorBuy180,582.002.00361,164.00181,618.00https://www.sec.gov/Archives/edgar/data/1585608/000110465919041840/0001104659-19-041840-index.htm